Lacrimal sac tumors presenting as lacrimal obstruction. Retrospective study in Mexican patients 2007–2012

Coloma-González, I.; Flores-Preciado, J.; Ceriotto, A.; Corredor-Casas, Sonia; Salcedo-Casillas, Guillermo

doi:10.1016/j.oftale.2014.02.007

Cited by 2 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The peak incidences of lacrimal sac tumor are in fifth decade of life [4]. Localized painless or painful medial Our patient presented at the age of 28 years old which is younger compare to other cases reported before [2][3][4][5][6]. Review done by Gao et al [7]showed mean age at the time of diagnosis was 56.4 years old.…”

Section: Discussionmentioning

confidence: 62%

See 1 more Smart Citation

Primary non hodgkin’s lymphoma of lacrimal sac presented as recurrent acute dacryocystitis: A case report

Ramli¹,

Hussein²,

Jaafar³

2017

JAD

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 62%

“…The presenting features are usually nonspecific, including epiphora, medial canthal swelling and redness which may be misleading. It may delay in diagnosis as it mimic primary nasolacrimal duct obstruction [2,3].…”

Section: Introductionmentioning

confidence: 99%

Primary non hodgkin’s lymphoma of lacrimal sac presented as recurrent acute dacryocystitis: A case report

Ramli¹,

Hussein²,

Jaafar³

2017

JAD

View full text Add to dashboard Cite

“…However, malignancy does pose additional concerns, such as recurrence and metastasis. 6 The optimal timing for a Jones tube placement after excising nasal or lacrimal drainage system malignancy remains unknown because the literature is limited to information on surgical efficacy, techniques, and complications. Although timing is unknown, survey respondents reported a range of 3 months to 5 years of waiting, with the most frequent time frame reported being one year (51.5% of responses).…”

Section: Discussionmentioning

confidence: 99%

Timing of Jones Tube Placement After Excision of Nasal or Lacrimal Drainage System Malignancy: A Survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)

Kornhauser,

Ponder,

Dockery

et al. 2023

OPTH

View full text Add to dashboard Cite

Purpose To elicit, from a survey of oculoplastic surgeons, the timing and reason for delaying Jones tube placement after the excision of nasal or lacrimal drainage system malignancy. Methods The authors reviewed current literature and distributed an anonymous survey to 627 members of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) to determine the length of time members wait to perform a Jones tube placement after the removal of nasal or lacrimal drainage system malignancy. The survey also included questions about the rationale for this waiting period. Results Fifty-eight members of ASOPRS (9.3%) responded to our survey, 49 (84.4%) of whom had performed Jones tube placement on patients who had an excision of a nasal or lacrimal drainage system malignancy. Nearly 52% of respondents waited one year for Jones tube placement. However, a sizeable number of respondents opted to wait five years (15.1%). The most common rationale for waiting was a concern for tumor recurrence (42 responses). Conclusion There is no consensus on when to perform Jones tube placement after the excision of nasal or lacrimal drainage system malignancy. This survey demonstrates a broad array of waiting periods between operations, although most surgeons wait 12 months.

show abstract

Lacrimal sac tumors presenting as lacrimal obstruction. Retrospective study in Mexican patients 2007–2012

Cited by 2 publications

References 9 publications

Primary non hodgkin’s lymphoma of lacrimal sac presented as recurrent acute dacryocystitis: A case report

Primary non hodgkin’s lymphoma of lacrimal sac presented as recurrent acute dacryocystitis: A case report

Timing of Jones Tube Placement After Excision of Nasal or Lacrimal Drainage System Malignancy: A Survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)

Contact Info

Product

Resources

About